Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine augmentation of exposure-based CBT for pediatric obsessive-compulsive disorder
ACTRN12609000370202Phase 2Completed
- Sponsor
- Dr Lara Farrell
- Start
- Apr 2009
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in obsessive compulsive disorder (OCD) comparing D-cycloserine plus CBT with Placebo plus CBT (2 arms). Primary endpoint: Obsessive-compulsive symptom severity. Started Apr 2009; status: completed.
02
Drugs
d-cycloserine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on ACTRN12609000370202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000370202.